» Articles » PMID: 32138283

Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials

Abstract

Background: It is unclear whether or not ultrasound-guided cannulation (UGC) of the femoral artery is superior to the standard approach (SA) in reducing vascular complications and improving access success.

Objective: We sought to compare procedural and clinical outcomes of femoral UGC versus SA in patients undergoing percutaneous cardiovascular intervention (PCvI).

Methods: We searched EMBASE, MEDLINE, Scopus and web sources for randomized trials comparing UGC versus SA. We estimated risk ratio (RR) and standardized mean differences (SMDs) with 95% confidence intervals (CIs) for categorical and continuous variables, respectively. Primary efficacy endpoint was the success rate at the first attempt, while secondary efficacy endpoints were access time and number of attempts. Primary safety endpoints were the rates of vascular complications, while secondary endpoints were major bleeding, as well as access site hematoma, venepuncture, pseudoaneurysms and retroperitoneal hematoma. This meta-analysis has been registered on Centre for Open Science (OSF) (osf.io/fy82e).

Results: Seven trials were included, randomizing 3180 patients to UGC ( = 1564) or SA ( = 1616). Efficacy between UGC and SA was the main metric assessed in most of the trials, in which one third of the enrolled patients underwent interventional procedures. The success rate of the first attempt was significantly higher with UGC compared to SA, (82.0% vs. 58.7%; RR: 1.36; 95% CI: 1.17 to 1.57; < 0.0001; I = 88%). Time to access and number of attempts were significantly reduced with UGC compared to SA (SMD: -0.19; 95% CI: -0.28 to -0.10; < 0.0001; I = 22%) and (SMD: -0.40; 95% CI: -0.58 to -0.21; p < 0.0001; I = 82%), respectively. Compared with SA, use of UGC was associated with a significant reduction in vascular complications (1.3% vs. 3.0%; RR: 0.48; CI 95%: 0.25 to 0.91; = 0.02; I = 0%) and access-site hematoma (1.2% vs. 3.3%; RR: 0.41; CI 95%: 0.20 to 0.83; = 0.01; I = 27%), but there were non-significant differences in major bleeding (0.7% vs. 1.4%; RR: 0.57; CI 95%: 0.24 to 1.32; = 0.19; I = 0%). Rates of venepuncture were lower with UGC (3.6% vs. 12.1%; RR: 0.32; CI 95%: 0.20 to 0.52; < 0.00001; I = 55%).

Conclusion: This study, which included all available data to date, demonstrated that, compared to a standard approach, ultrasound-guided cannulation of the femoral artery is associated with lower access-related complications and higher efficacy rates. These results could be of great clinical relevance especially in the femoral cannulation of high risk patients.

Citing Articles

Transcatheter Arterial Embolization for Hemorrhagic Pelvic Fracture: Review Article.

Usui R, Kondo H Interv Radiol (Higashimatsuyama). 2024; 9(3):156-163.

PMID: 39559807 PMC: 11570184. DOI: 10.22575/interventionalradiology.2023-0015.


Killing two birds with one stone: percutaneous management of two simultaneous vascular complications after atrial fibrillation catheter ablation.

Dogan M, Menemencioglu C, Ates A, Canpolat U, Yorgun H, Aytemir K Postepy Kardiol Interwencyjnej. 2024; 20(3):372-373.

PMID: 39464596 PMC: 11506405. DOI: 10.5114/aic.2024.142237.


Femoral Large Bore Sheath Management: How to Prevent Vascular Complications From Vessel Puncture to Sheath Removal.

Paraggio L, Bianchini F, Aurigemma C, Romagnoli E, Bianchini E, Zito A Circ Cardiovasc Interv. 2024; 17(9):e014156.

PMID: 39166330 PMC: 11404769. DOI: 10.1161/CIRCINTERVENTIONS.124.014156.


Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices.

Sorrentino S, Di Costanzo A, Salerno N, Caracciolo A, Bruno F, Panarello A Curr Vasc Pharmacol. 2023; 22(2):79-87.

PMID: 38073100 DOI: 10.2174/0115701611233184231206100222.


Lp(a) in the Pathogenesis of Aortic Stenosis and Approach to Therapy with Antisense Oligonucleotides or Short Interfering RNA.

Di Costanzo A, Indolfi C, Franzone A, Esposito G, Spaccarotella C Int J Mol Sci. 2023; 24(19).

PMID: 37834387 PMC: 10573862. DOI: 10.3390/ijms241914939.


References
1.
Sorrentino S, Giustino G, Mehran R, Kini A, Sharma S, Faggioni M . Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents. J Am Coll Cardiol. 2017; 69(25):3055-3066. DOI: 10.1016/j.jacc.2017.04.011. View

2.
Jolly S, Yusuf S, Cairns J, Niemela K, Xavier D, Widimsky P . Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011; 377(9775):1409-20. DOI: 10.1016/S0140-6736(11)60404-2. View

3.
Azzalini L, Tosin K, Chabot-Blanchet M, Avram R, Ly H, Gaudet B . The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access: The Campeau Radial Paradox. JACC Cardiovasc Interv. 2015; 8(14):1854-64. DOI: 10.1016/j.jcin.2015.07.029. View

4.
Marquis-Gravel G, Tremblay-Gravel M, Levesque J, Genereux P, Schampaert E, Palisaitis D . Ultrasound guidance versus anatomical landmark approach for femoral artery access in coronary angiography: A randomized controlled trial and a meta-analysis. J Interv Cardiol. 2018; 31(4):496-503. DOI: 10.1111/joic.12492. View

5.
Doyle B, Ting H, Bell M, Lennon R, Mathew V, Singh M . Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv. 2009; 1(2):202-9. DOI: 10.1016/j.jcin.2007.12.006. View